A178 BIOLOGIC THERAPY DURING PREGNANCY AS PER GUIDELINE RECOMMENDATIONS REDUCES ADVERSE PREGNANCY RELATED OUTCOMES

BACKGROUND: Inflammatory bowel disease (IBD) disease activity during pregnancy is associated with adverse neonatal and pregnancy-related outcomes. Biologics are used to suppress disease activity but crosses the placenta in the third trimester. Conflicting studies and guidelines on the timing of biol...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, J J, Govardhanam, V, Tandon, P, Huang, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Poster of Distinction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859375/
http://dx.doi.org/10.1093/jcag/gwab049.177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859375/
http://dx.doi.org/10.1093/jcag/gwab049.177

Ejemplares similares